Homo sapiens Protein: TNK2 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||
InnateDB Protein | IDBP-70930.7 | ||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||
Gene Symbol | TNK2 | ||||||||||||||||||||||||||||
Protein Name | tyrosine kinase, non-receptor, 2 | ||||||||||||||||||||||||||||
Synonyms | ACK; ACK-1; ACK1; p21cdc42Hs; | ||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000371341 | ||||||||||||||||||||||||||||
InnateDB Gene | IDBG-70926 (TNK2) | ||||||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||
Function | Non-receptor tyrosine-protein and serine/threonine- protein kinase that is implicated in cell spreading and migration, cell survival, cell growth and proliferation. Transduces extracellular signals to cytosolic and nuclear effectors. Phosphorylates AKT1, AR, MCF2, WASL and WWOX. Implicated in trafficking and clathrin-mediated endocytosis through binding to epidermal growth factor receptor (EGFR) and clathrin. Binds to both poly- and mono-ubiquitin and regulates ligand-induced degradation of EGFR, thereby contributing to the accumulation of EGFR at the limiting membrane of early endosomes. Downstream effector of CDC42 which mediates CDC42-dependent cell migration via phosphorylation of BCAR1. May be involved both in adult synaptic function and plasticity and in brain development. Activates AKT1 by phosphorylating it on 'Tyr-176'. Phosphorylates AR on 'Tyr-267' and 'Tyr-363' thereby promoting its recruitment to androgen-responsive enhancers (AREs). Phosphorylates WWOX on 'Tyr- 287'. Phosphorylates MCF2, thereby enhancing its activity as a guanine nucleotide exchange factor (GEF) toward Rho family proteins. Contributes to the control of AXL receptor levels. Confers metastatic properties on cancer cells and promotes tumor growth by negatively regulating tumor suppressor such as WWOX and positively regulating pro-survival factors such as AKT1 and AR. {ECO:0000269PubMed:10652228, ECO:0000269PubMed:11278436, ECO:0000269PubMed:16247015, ECO:0000269PubMed:16257963, ECO:0000269PubMed:16472662, ECO:0000269PubMed:17038317, ECO:0000269PubMed:18262180, ECO:0000269PubMed:18435854, ECO:0000269PubMed:19815557, ECO:0000269PubMed:20333297, ECO:0000269PubMed:20383201}. | ||||||||||||||||||||||||||||
Subcellular Localization | Cell membrane. Nucleus. Endosome. Cell junction, adherens junction {ECO:0000250}. Cytoplasmic vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasmic vesicle, clathrin-coated vesicle. Membrane, clathrin- coated pit. Note=The Tyr-284 phosphorylated form is found both in the membrane and nucleus. Colocalizes with EGFR on endosomes. Nuclear translocation is CDC42-dependent. | ||||||||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||||||||
Tissue Specificity | The Tyr-284 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages. It also shows a significant increase in expression in prostate cancers during the progressive stages. {ECO:0000269PubMed:16247015, ECO:0000269PubMed:20333297, ECO:0000269PubMed:20623637}. | ||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 88 experimentally validated interaction(s) in this database.
They are also associated with 6 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||
InterPro |
IPR000719
Protein kinase domain IPR001245 Serine-threonine/tyrosine-protein kinase catalytic domain IPR001452 SH3 domain IPR002290 Serine/threonine/dual specificity protein kinase, catalytic domain IPR009060 UBA-like IPR011009 Protein kinase-like domain IPR013761 Sterile alpha motif/pointed domain IPR015116 Cdc42 binding domain like IPR020635 Tyrosine-protein kinase, catalytic domain IPR021619 EGFR receptor inhibitor Mig-6 |
||||||||||||||||||||||||||||
PFAM |
PF00069
PF07714 PF00018 PF14604 PF09027 PF11555 |
||||||||||||||||||||||||||||
PRINTS |
PR00109
PR00452 |
||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||
SMART |
SM00326
SM00220 SM00219 |
||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||
SwissProt | Q07912 | ||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q07912 | ||||||||||||||||||||||||||||
TrEMBL | C9JDG3 | ||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||
Entrez Gene | 102723738 | ||||||||||||||||||||||||||||
UniGene | Hs.638864 | ||||||||||||||||||||||||||||
RefSeq | NP_001010938 | ||||||||||||||||||||||||||||
HUGO | HGNC:19297 | ||||||||||||||||||||||||||||
OMIM | 606994 | ||||||||||||||||||||||||||||
CCDS | CCDS33927 | ||||||||||||||||||||||||||||
HPRD | 06104 | ||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||
EMBL | AC124944 AK131539 BC008884 BC028164 L13738 | ||||||||||||||||||||||||||||
GenPept | AAA53570 AAH08884 AAH28164 BAD18675 | ||||||||||||||||||||||||||||